https://in.marketscreener.com/quote/stock/OCUGEN-INC-19157135/news-call-transcripts/
All Transcripts on Ocugen, Inc. (OCGN)
Find all the latest transcripts on Ocugen, Inc.
all transcriptsocugen incocgn
https://www.ldmicro.com/profile/ocgn/filings
Ocugen, Inc. (Nasdaq: OCGN) :: LD Micro
ocugen incnasdaqocgnldmicro
https://biotech-365.com/ocugen-inc-announces-closing-of-22-5-million-underwritten-registered-direct-offering-of-common-stock/
Ocugen, Inc. Announces Closing of $22.5 Million Underwritten Registered Direct Offering of Common...
ocugen incdirect offeringannouncesclosingmillion
https://public.com/stocks/ocgn/market-cap
Ocugen, Inc. (OCGN) Market Cap Today: Live Data & Historical Trends
The market cap of Ocugen, Inc. (OCGN) is $492.55M as of May 6, 2026. Track current and historical market cap trends with AI-powered fundamental data and custom...
ocugen incmarket captoday liveocgndata
https://www.checkman.com/quote/ocgn
Buy, Sell or Hold: [Ocugen, Inc.] OCGN Stock Price Forecast, Quote and Research | CheckMan
Stock price analysis for Ocugen, Inc. (OCGN), stock quote, stock research, rsi, macd, support, resistance and most important highlights.
buy sellocugen incstock priceholdocgn
https://eb5projects.com/updates/regional_center_updates/2208
Ocugen, Inc. Closes $6 Million In Series A Funding - Update on Global
Ocugen, Inc., a biopharmaceutical company developing treatments for sight-threatening diseases, today announced that it has closed a $6 million round of Series...
series a fundingocugen incclosesmillionupdate
https://marketnewsdata.com/2025/06/ocugen-inc-nasdaqocgn-financial-performance-a/
Ocugen, Inc. (NASDAQ:OCGN) and peers have negative Return on Invested Capital ratios. -...
Jun 20, 2025 - From Financial Modeling Prep: 2025-06-20 11:00:00 Ocugen, Inc. (NASDAQ:OCGN) focuses on gene therapies for blindness and vaccines for infectious diseases....
ocugen incnasdaqocgnpeersnegative